The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Signs of an inflammatory process, in particular increased pro-inflammatory cytokines and increased levels of prostaglandine E(2) (PGE(2)), have repeatedly been described in major depression (MD). As cyclooxygenase-2 (COX-2) inhibitors inhibit the PGE(2) production and the production of pro-inflammatory cytokines, we performed a therapeutic trial with the COX-2 inhibitor celecoxib. In a prospective, double-blind, add-on study, 40 patients suffering from an acute depressive episode were randomly assigned to either reboxetine and celecoxib or to reboxetine plus placebo. After a wash-out period, 20 patients received 4-10 mg reboxetine plus placebo and 20 received reboxetine plus 400 mg celecoxib for 6 weeks. The treatment effect was calculated by analysis of variance. There were no significant differences between groups in age, sex, duration or severity of disease or psychopathology, or reboxetine dose or plasma levels. Over 6 weeks, both groups of patients showed significant improvement in scores of the Hamilton Depression Scale. However, the celecoxib group showed significantly greater improvement compared to the reboxetine-alone group. Additional treatment with celecoxib has significant positive effects on the therapeutic action of reboxetine with regard to depressive symptomatology. Moreover, the fact that treatment with an anti-inflammatory drug showed beneficial effects on MD indicates that inflammation is related to the pathomechanism of the disorder, although the exact mechanisms remain to become elucidated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients in the reboxetine plus celecoxib group exhibited reductions in depression severity that were nearly twice as great (55% reduction) as those experienced by patients in the control group (33% reduction).”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Müller et al., 2006
In the citing paper
“75% of patients receiving reboxetine plus celecoxib were categorized as responders, compared to only 45% of patients receiving reboxetine plus placebo”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Müller et al., 2006
In the citing paper
“TNFα antagonists such as etanercept or infliximab and the COX-2 inhibitor celecoxib have all been found to alleviate depressive symptoms in double-blind, randomized, placebo-controlled studies”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Müller et al., 2006
In the citing paper
“One study found positive effects on mood in medically healthy, major depressed patients.52”
From Association of depressive disorders, depression characteristics and antidepressant medication with inflammation (2012) · cites this paper as [52]
In the citing paper
“from the administration of COX2 inhibitors to patients with major depression81”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [81]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The global burden of disease, 1990–2020
Lopez, A. D., & Murray, C. C. J. L. (1998) · Nature Medicine · doi:10.1038/3218 · Cited by 1,614
Cytokine-induced sickness behavior: where do we stand?
Dantzer, R. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0613 · Cited by 862
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997) · Cytokine · doi:10.1006/cyto.1997.0238 · Cited by 728
Maes, M., Scharpé, S., Meltzer, H. Y., Bosmans, E., Suy, E., Calabrese, J., & Cosyns, P. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90027-e · Cited by 439
Müller, N., Riedel, M., Scheppach, C., Brandstätter, B., Sokullu, S., Krampe, K., Ulmschneider, M., Engel, R. R., Möller, H.-J., & Schwarz, M. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1029 · Cited by 388
Self-citationFrommberger, U. H., Bauer, J., Haselbauer, P., Fräulin, A., Riemann, D., & Berger, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900219 · Cited by 362
Capuron, L., Ravaud, A., Miller, A. H., & Dantzer, R. (2004) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2003.11.004 · Cited by 236
Song, C., Lin, A., Bonaccorso, S., Heide, C., Verkerk, R., Kenis, G., Bosmans, E., Scharpe, S., Whelan, A., Cosyns, P., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00025-1 · Cited by 232
Cited by
Items 501–600 of 802
Kavakbasi, E., Sampson, E., Mills, N. T., Hori, H., Schwarte, K., Hohoff, C., Schubert, K. O., Clark, S. R., Fourrier, C., & Baune, B. T. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15946 · Cited by 23
Yuan, C., Dai, C., Li, Z., Li, Z., Zhao, M., & Dong, S. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03012-3 · Cited by 19
Magnesium and major depression
Eby, G. A., Eby, K. L., & Murck, H. (2011) · University of Adelaide Press eBooks · doi:10.1017/upo9780987073051.024 · Cited by 20
Neuroimmune Pharmacology of Neurodegenerative and Mental Diseases
Shie, F., Chen, Y., Chen, C., & Ho, I.-K. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9241-8 · Cited by 21
Lee, H., Rao, J. S., Chang, L., Rapoport, S. I., & Bazinet, R. P. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0803-2 · Cited by 21
Pearlman, D. M., Brown, J. R., MacKenzie, T. A., Hernandez, F., & Najjar, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111110 · Cited by 19
Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study
de Vries, E. F. J., Doorduin, J., Vellinga, N. A., van Waarde, A., Dierckx, R., & Klein, H. C. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.01.005 · Cited by 20
Buchmann, A., Ritter, C. J., Müller, S. T., Haynes, M., Ghisleni, C., Tuura, R., & Hasler, G. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.02.017 · Cited by 20
Murata, S., Baig, N., Decker, K. J., & Halaris, A. E. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091408 · Cited by 21
Branchi, I., Viglione, A., Vai, B., Cirulli, F., Benedetti, F., & Poggini, S. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.103923 · Cited by 19
Gao, Y., Pan, K., Zhang, Y.-M., Qi, Y., Chen, W.-G., Zhou, T. J., Zong, H.-C., Guo, H., Zhao, J.-W., Liu, X., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01384-8 · Cited by 20
The Historical Development of Immunoendocrine Concepts of Psychiatric Disorders and Their Therapy
Steinberg, H., Kirkby, K. C., & Himmerich, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226136 · Cited by 21
Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo
He, J., Fang, P., Xiang, Z., Wang, C., Liu, T., Zhang, B., Wen, J. M., & Xu, R.-A. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s160316 · Cited by 19
Liu, K., Zhao, X., Lu, X., Zhu, X., Chen, H., Wang, M., Yan, W., Jing, L., Deng, Y., Yu, L., et al. (2018) · Psychological Medicine · doi:10.1017/s0033291718003616 · Cited by 18
Inflammation, Neurotoxins and Psychiatric Disorders
Myint, A.-M. (2013) · Modern trends in psychiatry · doi:10.1159/000343968 · Cited by 19
Vadalouca, A., Μoka, Ε., Chatzidimitriou, A., Siafaka, I., Sikioti, P., & Argyra, E. (2009) · Pain Practice · doi:10.1111/j.1533-2500.2009.00271.x · Cited by 21
Steinberg, H., & Himmerich, H. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.623717 · Cited by 17
Bloch, Y., Belmaker, R. H., Shvartzman, P., Romem, P., Bolotin, A., Bersudsky, Y., & Azab, A. N. (2021) · Scientific Reports · doi:10.1038/s41598-021-98245-9 · Cited by 17
Sokołowska, P., Bleibel, L., Owczarek, J., & Wiktorowska‐Owczarek, A. (2024) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/174243 · Cited by 23
Biomarkers of stress resilience: A review
Paribello, P., Branchi, I., Viglione, A., Mancini, G. F., Morena, M., Campolongo, P., & Manchia, M. (2024) · Neuroscience Applied · doi:10.1016/j.nsa.2024.104052 · Cited by 18
da Silva, D. M. A., Lopes, I. S., Oliveira, J. V. S., Júnior, M. A. S., Rebouças, M. D. O., Valentim, J. T., Vale, L. D. C., Capibaribe, V. C. C., de Carvalho, M. A. J., de Aquino, P. É. A., et al. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173778 · Cited by 20
Gerber, A. R., & Bale, T. L. (2012) · Endocrinology · doi:10.1210/en.2012-1601 · Cited by 16
Castillo, M. F. R., Murata, S., Schwarz, M., Schütze, G. A., Moll, N., Martin, B., Burger, B., Weidinger, E., Mueller, N., & Halaris, A. E. (2019) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2019.03.005 · Cited by 17
Self-citationAntidepressant Effects of NSAIDs in Rodent Models of Depression—A Systematic Review
Bay-Richter, C., & Wegener, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.909981 · Cited by 19
Serotonin, cytokines, p11, and depression
Snyder, S. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106103108 · Cited by 17
Using non-steroidal anti-inflammatory drugs in the treatment of depression.
Davis, A., Gilhooley, M. J., & Agius, M. (2010) · PubMed · Cited by 22
Sampson, E., Mills, N. T., Hori, H., Cearns, M., Schwarte, K., Hohoff, C., Schubert, K. O., Fourrier, C., & Baune, B. T. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.09.003 · Cited by 17
Mucuna pruriens, a Possible Treatment for Depressive Disorders
Mata-Bermúdez, A., Díaz-Ruiz, A., Silva-García, L. R., Gines-Francisco, E. M., Noriega‐Navarro, R., Ríos, C., Romero-Sánchez, H. A., Arroyo, D., Landa, A., & Navarro, L. (2024) · Neurology International · doi:10.3390/neurolint16060112 · Cited by 21
Measuring sickness behavior in the context of pancreatic cancer
Tobias, K. G., Rosenfeld, B. D., Pessin, H., & BREITBART, W. S. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.01.002 · Cited by 17
La inflamación y sus desencantos: papel de las citocinas en la fisiopatología de la depresión mayor
Miller, A. H., Maletic, V., & Raison, C. L. (2010) · Psiquiatría Biológica · doi:10.1016/j.psiq.2010.04.001 · Cited by 20
Neurobiología de la depresión mayor y de su tratamiento farmacológico
Cruzblanca, H., Centro Universitario de Investigaciones Biomédicas, U. D. C., Lupercio, P., Collas, J., & Castro, E. (2016) · Salud Mental · doi:10.17711/sm.0185-3325.2015.067 · Cited by 40
Alboni, S., Benatti, C., Capone, G., Tascedda, F., & Brunello, N. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.063 · Cited by 18
Shvartsur, R., Agam, G., Uzzan, S., & Azab, A. N. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050901 · Cited by 17
Archer, T., Kostrzewa, R. M., Palomo, T., & Beninger, R. J. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9161-7 · Cited by 17
Experimental Confirmation of New Drug–Target Interactions Predicted by Drug Profile Matching
Végner, L., Peragovics, Á., Tombor, L., Jelinek, B., Czobor, P., Bender, A., Simon, Z., & Málnási‐Csizmadia, A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400813y · Cited by 18
Psychiatric Disorders - Worldwide Advances
Uehara, T. (2011) · InTech eBooks · doi:10.5772/1289 · Cited by 16
Abdoli, A. (2017) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12389 · Cited by 17
Inflammation Through a Psychoneuroimmunological Lens
Bennett, J. M., Gillie, B. L., Lindgren, M. E., Fagundes, C. P., & Kiecolt-Glaser, J. K. (2013) · Handbook of Systems and Complexity in Health · doi:10.1007/978-1-4614-4998-0_19 · Cited by 15
Kinderlehrer, D. A. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s500337 · Cited by 18
Rodríguez-Quiroga, A., MacDowell, K. S., Leza, J. C., Carrasco, J. L., & Díaz‐Marsá, M. (2020) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-020-00922-7 · Cited by 16
Liu, S., Liu, Q., Ju, Y., & Liu, L. (2021) · Scientific Reports · doi:10.1038/s41598-021-88560-6 · Cited by 15
Antenatal depression, psychotropic medication use, and inflammation among pregnant women
Miller, E. S., Grobman, W. A., Culhane, J. F., Adam, E. K., Buß, C., Entringer, S., Miller, G. E., Wadhwa, P. D., Keenan‐Devlin, L. S., & Borders, A. E. B. (2018) · Archives of Women s Mental Health · doi:10.1007/s00737-018-0855-9 · Cited by 16
Mesripour, A., Rabian, N., & Yegdaneh, A. (2019) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2018-0207 · Cited by 15
Neuroendocrine–Immune Interactions: Implications for Health and Behavior
Pace, T. W. W., Raison, C. L., & Miller, A. H. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00083-8 · Cited by 15
Köhler‐Forsberg, O., Sylvia, L. G., Thase, M. E., Calabrese, J. R., Deckersbach, T., Tohen, M. F., Bowden, C. L., McInnis, M. G., Kocsis, J. H., Friedman, E. S., et al. (2017) · Depression and Anxiety · doi:10.1002/da.22601 · Cited by 15
Akiyama, S., Nagai, H., Oike, S., Horikawa, I., Shinohara, M., Lü, Y., Futamura, T., Shinohara, R., Kitaoka, S., & Furuyashiki, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-15461-7 · Cited by 19
Effect of a water extract of Curcuma longa on emotional states in healthy participants
Kawasaki, K., Muroyama, K., & Murosaki, S. (2018) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.17-020 · Cited by 15
C-reactive protein in major depressive disorder: Promise and challenge
Halaris, A. E., Prochaska, D., Stefanski, A., & Filip, M. (2022) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2022.100427 · Cited by 22
Nascimento, C. F., Nunes, P. V., Suemoto, C. K., Rodriguez, R. D., Leite, R. E. P., Grinberg, L. T., Pasqualucci, C. A., Nitríni, R., Filho, W. J., Brentani, H., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.08.034 · Cited by 14
Brenner, L. A., Stearns‐Yoder, K. A., Stamper, C. E., Hoisington, A. J., Brostow, D. P., Hoffmire, C. A., Forster, J. E., Donovan, M. L., Ryan, A. T., Postolache, T. T., et al. (2022) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2022.100960 · Cited by 13
Toft, H., Lien, L., Neupane, S. P., Abebe, D., Tilden, T., Wampold, B. E., & Bramness, J. G. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.36 · Cited by 15
Real, A. G., Fontanari, A. M. V., Costa, A. B., Soll, B. M. B., Bristot, G., de Oliveira, L. F., Kamphorst, A. M., Schneider, M. A., & Lobato, M. I. R. (2021) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2020-0007 · Cited by 17
The hygiene hypothesis and affective and anxiety disorders
Rook, G. A. W., & Lowry, C. A. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8903-1_11 · Cited by 17
Association between systemic inflammatory markers and depression: A meta-analysis
Jiang, X., Pei, J., Diao, H., He, Q., Zhu, T., Liu, Q., Cui, Y., Fang, F., & Cui, W. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.07.005 · Cited by 12
Esalatmanesh, S., Kashani, L., Khooshideh, M., Moghaddam, H. S., Ansari, S., & Akhondzadeh, S. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-07042-4 · Cited by 13
Diagnosis of Infectious or Inflammatory Psychosyndromes
Bechter, K. (2012) · The Open Neurology Journal · doi:10.2174/1874205x01206010113 · Cited by 12
Luo, W., Luo, Y., & Yang, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-66420-z · Cited by 14
Dinur, E., Goldenberg, H., Robinson, E., Naggan, L., Kozela, E., & Yirmiya, R. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0225 · Cited by 11
The anti-inflammation pharmacodynamics of lithium: Therapy of bipolar disorder
Zhou, Y., Zheng, W., Guo, F., Wu, S., & Zhong, C. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251326942 · Cited by 11
Su, H., Ma, C.-T., Lin, C., Wu, H., Chuang, Y., Chen, L., & Tsao, C.-W. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.07.011 · Cited by 13
Bhatt, S., Pundarikakshudu, K., Patel, P. K., Patel, N. V., Panchal, A. R., Shah, G. B., & Goswami, S. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12660 · Cited by 11
Halaris, A. E., & Leonard, B. E. (2019) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2019.05.005 · Cited by 12
Behavior and Medical Problems in Pet Animals
Fatjó, J., & Bowen, J. (2020) · Advances in Small Animal Care · doi:10.1016/j.yasa.2020.07.003 · Cited by 12
Montelukast induces beneficial behavioral outcomes and reduces inflammation in male and female rats
Rostevanov, I. S., Betesh-Abay, B., Nassar, A., Rubin, E., Uzzan, S., KAPLANSKI, J., Biton, L., & Azab, A. N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.981440 · Cited by 14
Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies
Kositsyn, Y. M., de Abreu, M. S., Kolesnikova, T. O., Lagunin, A. A., Poroikov, V., Harutyunyan, H. S., Yenkoyan, K. B., & Kalueff, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119482 · Cited by 12
Effects of olanzapine on LPS-induced inflammation in rat primary glia cells
Faour-Nmarne, C., & Azab, A. N. (2015) · Innate Immunity · doi:10.1177/1753425915613425 · Cited by 12
Oxidative Stress in Depression
Gałecki, P. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_190 · Cited by 12
MicroRNA–Messenger RNA Regulatory Network Mediates Disrupted TH17 Cell Differentiation in Depression
Wang, H., Liu, L., Chen, X., Zhou, C., Rao, X., Li, W., Li, W., Liu, Y., Fang, L., Zhang, H., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.824209 · Cited by 11
No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression
Serretti, A., Chiesa, A., Calati, R., Massat, I., Linotte, S., Kasper, S. F., Lecrubier, Y., Fink, M., Antonijevic, I. A., Forray, C., et al. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.11.023 · Cited by 11
Paradoxical Effect of LTB4 on the Regulation of Stress-Induced Corticosterone Production
Locachevic, G. A., Prado, M. K. B., Zoccal, K. F., Pereira, P. A. T., Sorgi, C. A., Bortolanza, M., Peti, A. P. F., Fogaça, M. V., Guimarães, F. S., Bel, E. D., et al. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00073 · Cited by 12
Wium‐Andersen, I. K., Wium‐Andersen, M. K., Jørgensen, M. B., & Osler, M. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.05.105 · Cited by 13
Uzzan, S., Rostevanov, I. S., Rubin, E., Benguigui, O., Marazka, S., KAPLANSKI, J., Agbaria, R., & Azab, A. N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031823 · Cited by 11
Shamim, M. A., Manna, S., Dwivedi, P., Swami, M. K., Sahoo, S., Shukla, R. K. G., Srivastav, S., Thaper, K., Saravanan, A., Anil, A., et al. (2023) · Medicine · doi:10.1097/md.0000000000035937 · Cited by 11
Gurvich, A., Begemann, M., Dahm, L., Sargin, D., Miskowiak, K. W., & Ehrenreich, H. (2014) · Bipolar Disorders · doi:10.1111/bdi.12223 · Cited by 10
Shahini, N., Talaeı, A., Shalbafan, M., Farıdhosseını, F., & Ziaee, M. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.1998.1 · Cited by 11
Murata, S., Castillo, M. F. R., Murphy, M. L. M., Schwarz, M., Moll, N., Martin, B., Weidinger, E., Leitner, B., Mueller, N., & Halaris, A. E. (2019) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2019.07.001 · Cited by 10
Self-citationA Fast-Binding, Functionally Reversible, COX‑2 Radiotracer for CNS PET Imaging
Placzek, M. S., Wilton, D. K., Weïwer, M., Manter, M. A., Reid, S. E., Meyer, C. J., Campbell, A. J., Bajrami, B., Bigot, A., Bricault, S., et al. (2024) · ACS Central Science · doi:10.1021/acscentsci.3c01564 · Cited by 10
Inflammation control reverses treatment-resistance in bipolar depression
Halaris, A. E., Alvi, N., Meresh, E. S., & Sharma, A. (2014) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2014.01.151 · Cited by 9
Improving depression and reducing cardiac events: Which is the chicken and which is the egg?
Ziegelstein, R. C. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.02.005 · Cited by 11
Boufidou, F., & Halaris, A. E. (2017) · Modern trends in psychiatry · doi:10.1159/000470814 · Cited by 9
Novel Therapeutic Targets for Major Depressive Disorder
Lazar, M. A., & McIntyre, R. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00034-2 · Cited by 10
Rao, X., Liu, L., Wang, H., Yu, Y., Li, W., Chai, T., Zhou, W., Ji, P., Song, J., Wei, H., et al. (2021) · Experimental Neurobiology · doi:10.5607/en20055 · Cited by 10
Huang, S., Galaj, E., Wang, J., Guo, Y., Wang, S., Shi, M., Yin, X., Liu, K., Luo, Y., Meng, L., et al. (2022) · Brain and Behavior · doi:10.1002/brb3.2833 · Cited by 10
Anti-Inflammatory Therapy as a Promising Target in Neuropsychiatric Disorders
Ballaz, S., & Bourin, M. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_20 · Cited by 16
The Future of Psychoneuroimmunology: Promises and Challenges
Halaris, A. E., Bechter, K., Haroon, E., Leonard, B. E., Miller, A. H., Pariante, C. M., & Zunszain, P. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-70554-5_15 · Cited by 11
Inflammatory Biomarkers and Depression
Müller, N., Myint, A.-M., & Schwarz, M. (2010) · Springer eBooks · doi:10.1007/978-1-4614-0785-0_7 · Cited by 10
Self-citationMetabolomics: A Global Biochemical Approach to the Discovery of Biomarkers for Psychiatric Disorders
Kaddurah‐Daouk, R., Soares, J. C., & Quinones, M. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_6 · Cited by 11
Biological Models of Unipolar Depression
Cleare, A. J. (2004) · Wiley eBooks · doi:10.1002/9780470696385.ch2 · Cited by 10
Bengmark, S., & Gil, Á. (2007) · Nutrición Hospitalaria · Cited by 24
Preventive role of mirtazapine in methotrexate induced nephrotoxicity in rats
Uzkeser, H., Şener, E., Bakan, E., & Hacımüftüoğlu, A. (2012) · ScienceAsia · doi:10.2306/scienceasia1513-1874.2012.38.129 · Cited by 11
Sakhvidi, M. N., salami, Z., Mosadegh, M., Bidaki, R., Fallahzadeh, H., Salehabadi, R., & Arjmandi, M. (2023) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174231210567 · Cited by 7
Nassar, A., KAPLANSKI, J., & Azab, A. N. (2024) · Pharmaceuticals · doi:10.3390/ph17101271 · Cited by 8
Hu, X.-J., Pan, L., & Li, W. (2022) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/155802 · Cited by 10
Anti-Inflammatory Effect of Traditional Chinese Medicine on the Concept of Mind-Body Interface
Tsai, S.-T., Nithiyanantham, S., Satyanarayanan, S. K., & Su, K. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_19 · Cited by 9
Inflammatory pathology in depression and suicide: a mechanistic distillation of clinical correlates
Costanza, A., Amerio, A., Aguglia, A., Magnani, L., Parise, A., Nguyen, K. D., Berardelli, I., Pompili, M., Amore, M., & Serafini, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1479471 · Cited by 7
Rahmawati, N. A., Karimah, A., & Amin, M. M. (2021) · Jurnal Psikiatri Surabaya · doi:10.20473/jps.v10i2.22045 · Cited by 7
Antidepressant pharmacotherapy: focus on sex differences in neuroimmunopharmacological crossroads
Pitychoutis, P. M., Tsitsilonis, O., & Papadopoulou‐Daifoti, Z. (2010) · Future Neurology · doi:10.2217/fnl.10.28 · Cited by 7
Zhang, Q., Yang, L., Li, C., Zhang, Y., Li, R., Jia, F., Wang, L., Ma, X., Yao, K., Tian, H., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.02.053 · Cited by 6
Zhou, K., Xie, Y., Xie, X., Li, H., Liang, T., Li, J., & Liu, J. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119437 · Cited by 6
Gammoh, O., Durand, H., Abu-Shaikh, H., & Alsous, M. M. (2023) · Electronic Journal of General Medicine · doi:10.29333/ejgm/13089 · Cited by 9
Metadata
- Authors
- Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., Möller, H.-J., Arolt, V, & Riedel, M.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- University of Münster (DE)
- Corresponding author
- Müller, N
- Venue
- Molecular Psychiatry
- Published
- 2006-02-21
- Volume
- 11
- Issue
- 7
- Pages
- 680-684
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2049808835
- Cited by
- 794
- References
- 37
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 24 · 2023: 30 · 2022: 42 · 2021: 42 · 2020: 37 · 2019: 44 · 2018: 52 · 2017: 45 · 2016: 42 · 2015: 54 · 2014: 53 · 2013: 61 · 2012: 50
- FWCI
- 20.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- celecoxib, COX-2 inhibitors, major depressive disorder, reboxetine, anti-inflammatory therapy, inflammatory cytokines, prostaglandin E2, adjunctive therapy, acute depressive episode
- MeSH terms
- Celecoxib, Reboxetine, Adult, Antidepressive Agents, Depressive Disorder, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Inflammation, Lorazepam, Male, Middle Aged, Morpholines, Patient Dropouts, Pilot Projects, Psychological Tests, Pyrazoles, Serotonin, Severity of Illness Index, Sulfonamides, Anti-Anxiety Agents, Dinoprostone, Interleukin-6, Adrenergic Uptake Inhibitors, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.